Nearly 75 million doses of the vaccine against the novel coronavirus have been administered across China, a spokesman for the National Health Commission said.
"Overall, the Covid-19 response in China has been conducted soundly," Xinhua news agency quoted spokesman Mi Feng as saying at a press conference on Sunday.
"However, more accurate and effective epidemic prevention and control measures are still needed to ensure that there are no large-scale rebounds in cases."
China's annual vaccine production can fully meet the whole country's needs, as judged by the existing production arrangements, Mao Junfeng, an official from the Ministry of Industry and Information Technology, said at the same press conference.
China has authorised five Covid-19 vaccines for conditional marketing or emergency use.
These are three inactivated vaccines, one adenovirus vector vaccine, and one recombinant protein subunit vaccine, Mao noted.
Mi said now in Chinese regions where the pandemic risk is at a low level, people with a "green" health QR code may travel in an orderly manner on the premise that their body temperatures are normal and they follow necessary personal protection requirements.
--IANS
ksk/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)